BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for 89bio, Inc. (ETNB)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for 89bio, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-14
4:07 pm
Sale		 2024-12-31 13G 89bio, Inc.
ETNB		 BIOTECHNOLOGY VALUE FUND L P 4,333,885
3.600%		 -2,477,746decrease
(-36.38%)		 Filing
2024-11-14
4:30 pm
Sale		 2024-09-30 13G 89bio, Inc.
ETNB		 BIOTECHNOLOGY VALUE FUND L P 6,811,631
6.400%		 -756,849decrease
(-10.00%)		 Filing
2024-02-14
09:58 am
Purchase		 2023-12-31 13G 89bio, Inc.
ETNB		 BIOTECHNOLOGY VALUE FUND L P 7,568,480
7.800%		 4,047,354increase
(+114.94%)		 Filing
2023-02-14
12:00 pm
Sale		 2022-12-31 13G 89bio, Inc.
ETNB		 BIOTECHNOLOGY VALUE FUND L P 3,521,126
6.500%		 -376,874decrease
(-9.67%)		 Filing
2022-07-11
5:03 pm
Purchase		 2022-06-29 13G 89bio, Inc.
ETNB		 BIOTECHNOLOGY VALUE FUND L P 3,898,000
9.990%		 3,898,000increase
(New Position)		 Filing